IRIDEX Corporation (IRIX)
NASDAQ: IRIX · Real-Time Price · USD
1.000
+0.010 (1.01%)
Apr 1, 2025, 10:23 AM EDT - Market open
IRIDEX Employees
IRIDEX had 111 employees as of December 30, 2023. The number of employees decreased by 19 or -14.62% compared to the previous year.
Employees
111
Change (1Y)
-19
Growth (1Y)
-14.62%
Revenue / Employee
$438,459
Profits / Employee
-$80,270
Market Cap
16.79M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
IRIX News
- 4 days ago - IRIDEX Corporation (IRIX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 days ago - Iridex Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 13 days ago - Iridex Announces Strategic Investment in the Company - GlobeNewsWire
- 18 days ago - Iridex Comments on Recent Stock Price Volatility - GlobeNewsWire
- 18 days ago - Iridex to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025 - GlobeNewsWire
- 3 months ago - Iridex Announces Milestone Five-Year Study Confirms the Long-Term Effectiveness and Safety of MicroPulse Transscleral Cyclophotocoagulation for Glaucoma Management - GlobeNewsWire
- 4 months ago - Iridex Comments on Changing Glaucoma Reimbursement Landscape - GlobeNewsWire
- 4 months ago - IRIDEX Corporation (IRIX) Q3 2024 Earnings Call Transcript - Seeking Alpha